AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21084270 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (800 IU/d)
Number of subjects: 92
Study 21084270 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (2 g/d) and Vitamin D3 (800 IU/d)
Number of subjects: 92
Study 21084270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 19359985 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (200 to 800 mg daily for 2- to 8-month periods)
Number of subjects: 312
Study 17540200 — intervention group
Group type: EXPERIMENTAL
Intervention: Fontan group (30 patients after the Fontan procedure)
Number of subjects: 85
Study 17540200 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanotic group (29 patients with cyanotic heart disease)
Number of subjects: 85
Study 17540200 — intervention group
Group type: COMPARATOR
Intervention: Control group (26 patients with cyanotic heart disease after biventricular repair)
Number of subjects: 85
Study 17540200 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with APCs
Number of subjects: 85
Study 14706761 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy isoflavones + melatonin
Number of subjects: 262
Study 14706761 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy isoflavones alone
Number of subjects: 262
Study 14706761 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin alone
Number of subjects: 262
Study 14706761 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262
Study 11412293 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous-assisted ventilation
Number of subjects: 33
Study 11412293 — intervention group
Group type: COMPARATOR
Intervention: Intermittent negative-pressure ventilation
Number of subjects: 33
Study 9402168 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel, Docetaxel, Epirubicin
Number of subjects: 704
Study 8213685 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-minute orthopedic screening examination
Number of subjects: 259
Study 8213685 — intervention group
Group type: COMPARATOR
Intervention: History alone
Number of subjects: 259
Study 8213685 — intervention group
Group type: COMPARATOR
Intervention: Detailed orthopedic examination
Number of subjects: 259
Study 3802704 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (1 mg/min for 15 minutes)
Number of subjects: 0
Study 3802704 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 0
Study 3802704 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol and labetalol
Number of subjects: 0
Study 28011799 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-procedural burden of supraventricular ectopic complexes (SVEC) categorized into quartiles: 0-72, 73-212, 213-782, ≥783 SVEC/day
Number of subjects: 125
Study 28011799 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-procedural burden of SVEC (≥213) in patients with early AF recurrence <90 days after catheter ablation
Number of subjects: 125
Study 28011799 — intervention group
Group type: EXPERIMENTAL
Intervention: Low ectopy burden in patients with early AF recurrence
Number of subjects: 125
Study 27631143 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback
Number of subjects: 112
Study 27631143 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 112
Study 27631143 — intervention group
Group type: COMPARATOR
Intervention: Physical Activity
Number of subjects: 112
Study 23942059 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits for male partner HIV counselling and testing
Number of subjects: 300
Study 23942059 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based invitations for male partner HIV counselling and testing
Number of subjects: 300
Study 22475307 — intervention group
Group type: EXPERIMENTAL
Intervention: Food associated with familiar characters (e.g., sugary or salty snacks)
Number of subjects: 0
Study 22475307 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy food branded with a favored character
Number of subjects: 0
Study 22475307 — intervention group
Group type: EXPERIMENTAL
Intervention: Character branding (favored character vs. unknown character)
Number of subjects: 0
Study 20353747 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel besylate (test formulation)
Number of subjects: 40
Study 20353747 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel bisulfate (reference formulation)
Number of subjects: 40
Study 19027436 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo exposure therapy
Number of subjects: 72
Study 19027436 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality exposure therapy
Number of subjects: 72
Study 15880252 — intervention group
Group type: COMPARATOR
Intervention: Aquatic respiratory exercise program
Number of subjects: 81
Study 15880252 — intervention group
Group type: COMPARATOR
Intervention: Non-aquatic respiratory exercise program
Number of subjects: 81
Study 15880252 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 81
Study 12520629 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate (4.5 g) administered after an overnight fast
Number of subjects: 0
Study 12520629 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate (4.5 g) administered after a high-fat meal
Number of subjects: 0
Study 12520629 — intervention group
Group type: COMPARATOR
Intervention: Sodium oxybate (4.5 g)
Number of subjects: 0
Study 11574436 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia (blood glucose 2.59 [0.19] mmol/l)
Number of subjects: 20
Study 11574436 — intervention group
Group type: COMPARATOR
Intervention: Euglycemia (controlled euglycemia at 4.50 [0.22] mmol/l)
Number of subjects: 20
Study 9166993 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture analgesia (EA)
Number of subjects: 59
Study 9166993 — intervention group
Group type: COMPARATOR
Intervention: Conventional meperidine analgesia (MA)
Number of subjects: 59
Study 9166993 — intervention group
Group type: EXPERIMENTAL
Intervention: Both EA and MA
Number of subjects: 59
Study 8243791 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 200 micrograms twice daily
Number of subjects: 120
Study 8243791 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP) 200 micrograms twice daily
Number of subjects: 120
Study 3808875 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol drink
Number of subjects: 40
Study 3808875 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 40
Study 31454929 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Interval Training Group (AITG)
Number of subjects: 52
Study 31454929 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 52
Study 28895142 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic pancreatoduodenectomy
Number of subjects: 64
Study 28895142 — intervention group
Group type: COMPARATOR
Intervention: Open pancreatoduodenectomy
Number of subjects: 64
Study 25630447 — intervention group
Group type: EXPERIMENTAL
Intervention: EXCEL II stent system (PCI)
Number of subjects: 45
Study 22321813 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic pyeloplasty (LP)
Number of subjects: 57
Study 22321813 — intervention group
Group type: COMPARATOR
Intervention: Open pyeloplasty (OP)
Number of subjects: 57
Study 21612468 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate (1000 mg) with prednisone (5 mg twice daily)
Number of subjects: 1195
Study 21612468 — intervention group
Group type: COMPARATOR
Intervention: Placebo with prednisone (5 mg twice daily)
Number of subjects: 1195
Study 19218816 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab administered subcutaneously every 2 or 4 weeks based on serum IgE level and body weight.
Number of subjects: 34
Study 16914695 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 21
Study 16914695 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 14977692 — intervention group
Group type: EXPERIMENTAL
Intervention: Swaddling
Number of subjects: 25
Study 14977692 — intervention group
Group type: COMPARATOR
Intervention: Massage
Number of subjects: 25
Study 11558059 — intervention group
Group type: EXPERIMENTAL
Intervention: Original‐Golytely‐salt
Number of subjects: 310
Study 11558059 — intervention group
Group type: EXPERIMENTAL
Intervention: Oralav
Number of subjects: 310
Study 11558059 — intervention group
Group type: EXPERIMENTAL
Intervention: Delcoprep
Number of subjects: 310
Study 9770887 — intervention group
Group type: EXPERIMENTAL
Intervention: Helicobacter pylori (Hp) colonization
Number of subjects: 31
Study 9770887 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti Hp IgG antibodies
Number of subjects: 31
Study 9770887 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic antral gastritis
Number of subjects: 31
Study 9770887 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic duodenitis
Number of subjects: 31
Study 9770887 — intervention group
Group type: EXPERIMENTAL
Intervention: Age > 10 years
Number of subjects: 31
Study 7541176 — intervention group
Group type: EXPERIMENTAL
Intervention: Low PCO2
Number of subjects: 0
Study 7541176 — intervention group
Group type: EXPERIMENTAL
Intervention: High PCO2
Number of subjects: 0
Study 7541176 — intervention group
Group type: EXPERIMENTAL
Intervention: Haldane effect correction
Number of subjects: 0
Study 7541176 — intervention group
Group type: EXPERIMENTAL
Intervention: HE-induced delta pH
Number of subjects: 0
Study 3251481 — intervention group
Group type: COMPARATOR
Intervention: Safety education courses organized by agricultural and forestry organizations, Local Safety Inspectorate, and public health services; location close to participants' farms; specific details on dosage and duration not available.
Number of subjects: 0
Study 3251481 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety education courses; specific details on dosage and duration not available.
Number of subjects: 0
Study 1999027 — intervention group
Group type: COMPARATOR
Intervention: Conventional protocol
Number of subjects: 293
Study 1999027 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated protocol
Number of subjects: 293
Study 1251775 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase and heparin
Number of subjects: 15
Study 1251775 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 15
Study 1251775 — intervention group
Group type: COMPARATOR
Intervention: Phenprocoumon
Number of subjects: 15
Study 1251775 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin or streptokinase
Number of subjects: 15
Study 1251775 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 15
Study 1251775 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombosis in femoral and/or iliac vein
Number of subjects: 15
Study 1251775 — intervention group
Group type: COMPARATOR
Intervention: Thrombosis in popliteal vein or lower
Number of subjects: 15
Study 28494656 — intervention group
Group type: EXPERIMENTAL
Intervention: In-service training workshop on ADHD
Number of subjects: 274
Study 28235531 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced dose (0.5mg/kg) of propofol with divided remifentanil injections and moderate hyperventilation (ETCO2 of 30‐35mmHg) (group RP/H)
Number of subjects: 60
Study 28235531 — intervention group
Group type: COMPARATOR
Intervention: Standard dose (1mg/kg) of propofol and normoventilation (ETCO2 of 40‐45mmHg) (group P/N)
Number of subjects: 60
Study 28235531 — intervention group
Group type: COMPARATOR
Intervention: Reduced dose (0.5mg/kg) of propofol with divided remifentanil injections and normoventilation (group RP/N)
Number of subjects: 60
Study 25332458 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 16412
Study 25332458 — intervention group
Group type: COMPARATOR
Intervention: Prescribed smoking cessation medications
Number of subjects: 16412
Study 25332458 — intervention group
Group type: COMPARATOR
Intervention: Over-the-counter medications
Number of subjects: 16412
Study 25332458 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy
Number of subjects: 16412
Study 23286257 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam and pentazocine (7.5 mg)
Number of subjects: 160
Study 23286257 — intervention group
Group type: COMPARATOR
Intervention: Midazolam only
Number of subjects: 160
Study 20026871 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine 25 to 100 mg/day
Number of subjects: 0
Study 20026871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19563190 — intervention group
Group type: EXPERIMENTAL
Intervention: Fire-needle therapy
Number of subjects: 60
Study 19563190 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture
Number of subjects: 60
Study 16641466 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (EM) susceptibility testing
Number of subjects: 222
Study 16641466 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin (CM) susceptibility testing
Number of subjects: 222
Study 16641466 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of ermB, ermTR, and mefA/E antibiotic resistance genes
Number of subjects: 222
Study 15566374 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience with a relatively easy symbolic retrieval task
Number of subjects: 3
Study 11472278 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled Ventilation (CV group)
Number of subjects: 31
Study 11472278 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous Breathing (SB group)
Number of subjects: 31
Study 9723625 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E therapy
Number of subjects: 0
Study 9723625 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7521724 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative adjuvant IL-2 therapy
Number of subjects: 12
Study 7521724 — intervention group
Group type: COMPARATOR
Intervention: Hepatic resection without IL-2
Number of subjects: 12
Study 7521724 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatic resection after IL-2 therapy
Number of subjects: 12
Study 3050517 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin, ticarcillin, and amikacin
Number of subjects: 101
Study 30604674 — intervention group
Group type: EXPERIMENTAL
Intervention: PAFAC score derived from multivariable logistic regression model
Number of subjects: 1307
Study 30604674 — intervention group
Group type: EXPERIMENTAL
Intervention: PAFAC score applied to validation cohort
Number of subjects: 1307
Study 28498189 — intervention group
Group type: EXPERIMENTAL
Intervention: POC CD4 testing plus CD4-specific counseling
Number of subjects: 1150
Study 28498189 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (SOC)
Number of subjects: 1150
Study 25790213 — intervention group
Group type: EXPERIMENTAL
Intervention: WebTIPS program
Number of subjects: 82
Study 25790213 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 82
Study 24001379 — intervention group
Group type: EXPERIMENTAL
Intervention: BB-UVA (15 J/cm²)
Number of subjects: 40
Study 24001379 — intervention group
Group type: COMPARATOR
Intervention: NB-UVB
Number of subjects: 40
Study 21358477 — intervention group
Group type: EXPERIMENTAL
Intervention: Bryan cervical disc arthroplasty
Number of subjects: 48
Study 21358477 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion
Number of subjects: 48
Study 18581619 — intervention group
Group type: EXPERIMENTAL
Intervention: Test with 80% specificity (Sp) and any sensitivity (Se) including 100%
Number of subjects: 0
Study 18581619 — intervention group
Group type: EXPERIMENTAL
Intervention: Test with 90% specificity (Sp)
Number of subjects: 0
Study 18581619 — intervention group
Group type: EXPERIMENTAL
Intervention: Test with 95% specificity (Sp) and intermediate sensitivity (Se) (40%-60%)
Number of subjects: 0
Study 18581619 — intervention group
Group type: EXPERIMENTAL
Intervention: Test with 99% specificity (Sp) and very high sensitivity (Se) (over 90%)
Number of subjects: 0
Study 18581619 — intervention group
Group type: EXPERIMENTAL
Intervention: Correction procedures for large bias in disease burden estimates
Number of subjects: 0
Study 16567830 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone 45 mg/day for 24 weeks
Number of subjects: 12
Study 16567830 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 12
Study 12601502 — intervention group
Group type: EXPERIMENTAL
Intervention: Active nicotine gum
Number of subjects: 296
Study 12601502 — intervention group
Group type: COMPARATOR
Intervention: Inactive gum (placebo)
Number of subjects: 296
Study 11570313 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly combination injectable contraceptive (estradiol cypionate and medroxyprogesterone acetate)
Number of subjects: 0
Study 11570313 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive
Number of subjects: 0
Study 9543313 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 27
Study 9543313 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam
Number of subjects: 27
Study 7821473 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 6831
Study 7821473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6831
Study 3045028 — intervention group
Group type: COMPARATOR
Intervention: Potassium chloride 1 g twice/day
Number of subjects: 23
Study 3045028 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride 5 mg twice/day
Number of subjects: 23
Study 3045028 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamterene 75 mg twice/day
Number of subjects: 23
Study 31957732 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prevalence of blindness and severe visual impairment (VI)
Number of subjects: 3189
Study 31957732 — intervention group
Group type: EXPERIMENTAL
Intervention: Leading causes of blindness and severe VI
Number of subjects: 3189
Study 31957732 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgical coverage (CSC)
Number of subjects: 3189
Study 31957732 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of diabetes
Number of subjects: 3189
Study 31957732 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of diabetic retinopathy (DR)
Number of subjects: 3189
Study 30714058 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic milk chocolate (PMC)
Number of subjects: 150
Study 30714058 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic white chocolate (PWC)
Number of subjects: 150
Study 30714058 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic dark chocolate (PDC)
Number of subjects: 150
Study 30714058 — intervention group
Group type: COMPARATOR
Intervention: Conventional milk chocolate (MC)
Number of subjects: 150
Study 30714058 — intervention group
Group type: COMPARATOR
Intervention: Conventional white chocolate (WC)
Number of subjects: 150
Study 30714058 — intervention group
Group type: COMPARATOR
Intervention: Conventional dark chocolate (DC)
Number of subjects: 150
Study 27009057 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored behavioural medicine treatment
Number of subjects: 97
Study 27009057 — intervention group
Group type: COMPARATOR
Intervention: Exercise-based physiotherapy
Number of subjects: 97
Study 26395257 — intervention group
Group type: EXPERIMENTAL
Intervention: Training for GPs in identifying patients in need of palliative care and anticipatory care planning.
Number of subjects: 52
Study 26395257 — intervention group
Group type: COMPARATOR
Intervention: Control group (GPs did not receive training or coaching).
Number of subjects: 52
Study 24364361 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecologically Based Family Therapy (EBFT)
Number of subjects: 0
Study 24364361 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 0
Study 24364361 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Reinforcement Approach (CRA)
Number of subjects: 0
Study 22999398 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg enantiomeric excess hyperbaric levobupivacaine
Number of subjects: 120
Study 22999398 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg enantiomeric excess hyperbaric levobupivacaine
Number of subjects: 120
Study 22999398 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg enantiomeric excess hyperbaric levobupivacaine
Number of subjects: 120
Study 22999398 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses of enantiomeric excess hyperbaric levobupivacaine
Number of subjects: 120
Study 19528195 — intervention group
Group type: EXPERIMENTAL
Intervention: PROSPECT intervention
Number of subjects: 599
Study 19528195 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 599
Study 17391147 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 0
Study 17391147 — intervention group
Group type: COMPARATOR
Intervention: Neutral protamine Hagedorn (NPH) insulin
Number of subjects: 0
Study 15465626 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerophosphocholine (GPCh) in Alzheimer's patients
Number of subjects: 30
Study 15465626 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphocholine (PCh) in Alzheimer's patients
Number of subjects: 30
Study 15465626 — intervention group
Group type: EXPERIMENTAL
Intervention: Free choline (Ch) in Alzheimer's patients
Number of subjects: 30
Study 15465626 — intervention group
Group type: COMPARATOR
Intervention: Phosphocholine (PCh) in vascular dementia patients
Number of subjects: 30
Study 11394558 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivation-matched intervention with feedback reports tailored to psychological variables
Number of subjects: 0
Study 11394558 — intervention group
Group type: COMPARATOR
Intervention: Standard, print-based intervention
Number of subjects: 0
Study 9442340 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 26
Study 9442340 — intervention group
Group type: COMPARATOR
Intervention: Clozapine
Number of subjects: 26
Study 7766785 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening intervention (exact details not provided)
Number of subjects: 0
Study 7766785 — intervention group
Group type: EXPERIMENTAL
Intervention: Catch-up time method
Number of subjects: 0
Study 7766785 — intervention group
Group type: COMPARATOR
Intervention: Standard logrank test
Number of subjects: 0
Study 2611360 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen with Maalox (antacid)
Number of subjects: 19
Study 2611360 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen every 12 h from Day 3 to Day 8 with Maalox (antacid)
Number of subjects: 19